ArticleScientific reports2025
Clinical significance of Ureaplasma species in bronchopulmonary dysplasia development in preterm infants.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress on risk factors and clinical management ofFrontiers in pediatrics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This prospective study aimed to investigate colonization of Ureaplasma spp. in preterm infants to evaluate the relationship between Ureaplasma spp. colonization and BPD including other neonatal morbidities. A cohort of 357 preterm infants was examined for Ureaplasma spp. detection. Samples as nasopharyngeal swabs and gastric aspirates (non-intubated infants) whereas tracheal aspirates (intubated infants), were collected within 24 h of birth from infants with < 37 weeks gestational age (GA). Each sample was tested with culture and real-time polymerase chain reaction (RT-PCR) to confirm Ureaplasma spp. colonization. A total of 12 (3.3%) preterm infants (GA, 30.5 ± 2.2 weeks, P = 0.001; BW, 1,529 ± 501 g, P = 0.005) were positive for Ureaplasma spp. colonization. 23 (6.8%) preterm infants (GA, 28.7 ± 1.1 weeks, P = 0.001; BW, 1,234 ± 441 g, P = 0.005) developed BPD. Ureaplasma spp. colonization and BPD development showed an inverse relation with GA and birth weight (BW), and were associated with one antenatal factor (premature rupture of membranes; PROM), two natal factors (smaller GA, lower BW), one postnatal factor (longer use of supplemental oxygen), and p-value was significant for all factors (P < 0.05). Incidence of BPD in Ureaplasma spp. positive group was higher than in Ureaplasma spp. negative group (n = 3, 25% vs. n = 20, 6%, P = 0.001). Multivariate logistic regression analysis revealed a common correlation of Ureaplasma spp. colonization and BPD development with smaller GA (P = 0.012 & 0.001; 95%CI: 0.590-0.937 & 0.181-0.627), independent correlation of Ureaplasma spp. colonization with PROM (P = 0.002; 95%CI: 2.226-35.547) whereas independent correlation of BPD development with Ureaplasma spp. colonization (P = 0.037; 95%CI: 1.167-123.809) and more ventilator days (P = 0.003; 95%CI: 1.197-2.486). Ureaplasma spp. colonization is associated with PROM, smaller GA, and higher incidence of BPD. All preterm infants delivered by mothers with PROM and/or with smaller GAs should be investigated for Ureaplasma spp. colonization to anticipate BPD incidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.